-
Low-cost moist heat treatment of N95 masks eliminates SARS-CoV-2, bacteria
A new study shows that moist heat treatment of N95 masks eliminates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and bacteria, which would allow reuse of these scarce resources. The study is published in CMAJ (Canadian Medical Association Journal). -
AstraZeneca won't profit from COVID-19 vaccine in pandemic
Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment. Such promises were boosted by strong sales across its range of treatments during lockdown. Sales jumped by 14% to $12.6 billion in the first six months of 2020 and were helped by strong trading in new medicines, as well as cancer and respiratory medication.